DecisionPoint Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17K Sell
6
-5
-45% -$1.71K ﹤0.01% 312
2026
Q1
$3.87K Sell
11
-12
-52% -$4.28K ﹤0.01% 238
2025
Q4
$7.53K Buy
23
+12
+109% +$3.81K ﹤0.01% 217
2025
Q3
$3.28K Hold
11
﹤0.01% 200
2025
Q2
$3.2K Buy
+11
New +$3.12K ﹤0.01% 202
2023
Q4
Sell
-8
Closed -$2.15K 215
2023
Q3
$2.15K Buy
+8
New +$2K ﹤0.01% 192

Other funds holding AMGN

DecisionPoint Financial's AMGN Position: Q2 2026 in Review

DecisionPoint Financial reduced its Amgen (AMGN) stake by 45% in Q2 2026, selling an estimated $1.71K and leaving 6 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

DecisionPoint Financial first reported a position in AMGN in Q3 2023 and has held it in 6 quarters since. The position peaked at $7.53K in Q4 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • DecisionPoint Financial held 6 shares of Amgen worth $2.17K as of Q2 2026.
  • DecisionPoint Financial sold 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #312 holding.
  • DecisionPoint Financial first reported a position in Amgen in Q3 2023 and has held it in 6 quarters since.
  • DecisionPoint Financial's Amgen position peaked at $7.53K in Q4 2025.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.